https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-27 / Front Mol Biosci 2019;6:90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-27 / Front Mol Biosci 2019;6:902019-09-27 00:00:002020-12-14 17:15:172-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)2019-09-19 00:00:002020-08-26 14:07:32Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)2019-09-19 00:00:002019-09-19 00:00:00Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-11 / Front Oncol 2019;9:884
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-11 / Front Oncol 2019;9:8842019-09-11 00:00:002019-09-11 00:00:00Past, Current, and Future of Immunotherapies for Prostate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-838
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-8382019-09-01 00:00:002020-08-26 14:25:47Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-6662019-09-01 00:00:002019-09-01 00:00:00The current state of immunotherapy for gliomas: an eye toward the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-30 / Biomedicines 2019 Aug;7(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-30 / Biomedicines 2019 Aug;7(3)2019-08-30 00:00:002021-11-15 13:22:59Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-27 / Front Oncol 2019;9:811
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-27 / Front Oncol 2019;9:8112019-08-27 00:00:002019-08-27 00:00:00Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-2154
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-21542019-08-26 00:00:002020-08-26 14:20:49Application of Newcastle disease virus in the treatment of colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-17 / Int J Mol Sci 2019 Aug;20(16)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-17 / Int J Mol Sci 2019 Aug;20(16)2019-08-17 00:00:002019-08-17 00:00:00Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
